
How Everyone On Medicare Could End Up Paying For The Pricey New Alzheimer's Drug
The controversial new drug for Alzheimer's disease, Aduhelm, is priced at $56,000 a year for treatment -- but Alzheimer's patients won't be the only ones shouldering the cost.